Scimago Journal & Country Rank
menu
| Title | Type |  SJR |
H index | Total Docs. (2015) | Total Docs. (3years) | Total Refs. (2015) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2015) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 181 | Sp2 | trade journal | 0.100 Q4 | 2 | 0 | 109 | 0 | 0 | 92 | 0.00 | 0.00 |  |
| 180 | VacciMonitor | journal | 0.101 Q4 | 5 | 3 | 65 | 61 | 6 | 61 | 0.07 | 20.33 |  |
| 179 | Current Biomarkers | journal | 0.102 Q4 | 3 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 |  |
| 178 | Chinese Journal of Cancer Biotherapy | journal | 0.104 Q4 | 5 | 137 | 224 | 3625 | 8 | 219 | 0.04 | 26.46 |  |
| 177 | Methods in molecular medicine | book series | 0.106 Q4 | 59 | 21 | 4 | 590 | 0 | 4 | 0.00 | 28.10 |  |
| 176 | Open Bioactive Compounds Journal | journal | 0.106 Q4 | 6 | 0 | 4 | 0 | 1 | 4 | 0.25 | 0.00 | |
| 175 | International Journal of Medicinal Chemistry | journal | 0.115 Q4 | 4 | 1 | 2 | 22 | 1 | 2 | 0.50 | 22.00 | |
| 174 | Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry | journal | 0.129 Q4 | 16 | 39 | 139 | 2031 | 48 | 139 | 0.35 | 52.08 | |
| 173 | IEEE International Conference on Nano/Molecular Medicine and Engineering, NANOMED | conference and proceedings | 0.131 | 5 | 0 | 58 | 0 | 12 | 54 | 0.31 | 0.00 | |
| 172 | European Pharmaceutical Review | trade journal | 0.136 Q4 | 9 | 71 | 167 | 759 | 22 | 163 | 0.14 | 10.69 | |
| 171 | Current Enzyme Inhibition | journal | 0.143 Q4 | 19 | 17 | 46 | 570 | 11 | 40 | 0.24 | 33.53 |  |
| 170 | Gene Therapy and Molecular Biology | journal | 0.148 Q4 | 18 | 0 | 55 | 0 | 16 | 55 | 0.21 | 0.00 |  |
| 169 | Open Pharmacology Journal | journal | 0.149 Q4 | 6 | 0 | 9 | 0 | 3 | 8 | 0.00 | 0.00 | |
| 168 | Methods in Pharmacology and Toxicology | book series | 0.151 Q4 | 14 | 70 | 107 | 3676 | 23 | 100 | 0.21 | 52.51 | |
| 167 | Current Cancer Therapy Reviews | journal | 0.159 Q4 | 17 | 31 | 94 | 1962 | 33 | 86 | 0.33 | 63.29 | |
| 166 | Pteridines | journal | 0.162 Q4 | 19 | 18 | 50 | 743 | 21 | 49 | 0.39 | 41.28 |  |
| 165 | Journal of Biological Sciences (discontinued) | journal | 0.169 Q4 | 38 | 27 | 224 | 858 | 115 | 224 | 0.48 | 31.78 |  |
| 164 | Current Pharmacogenomics and Personalized Medicine | journal | 0.174 Q4 | 20 | 25 | 95 | 1706 | 40 | 79 | 0.43 | 68.24 | |
| 163 | Turkish Journal of Pharmaceutical Sciences | journal | 0.194 Q4 | 22 | 34 | 114 | 1055 | 53 | 114 | 0.22 | 31.03 |  |
| 162 | Forum on Immunopathological Diseases and Therapeutics | journal | 0.195 Q4 | 14 | 29 | 65 | 1633 | 21 | 58 | 0.15 | 56.31 | |
| 161 | Topics in Medicinal Chemistry | book series | 0.214 Q4 | 15 | 21 | 43 | 3177 | 25 | 39 | 0.41 | 151.29 | |
| 160 | Yaoxue Xuebao | journal | 0.216 Q4 | 36 | 258 | 794 | 6292 | 484 | 794 | 0.57 | 24.39 | |
| 159 | Current Pharmaceutical Analysis | journal | 0.224 Q4 | 27 | 41 | 128 | 1380 | 94 | 125 | 0.96 | 33.66 | |
| 158 | Genomics Data | journal | 0.227 Q4 | 27 | 277 | 111 | 2928 | 50 | 109 | 0.45 | 10.57 | |
| 157 | Nucleus (India) | journal | 0.243 Q4 | 17 | 33 | 79 | 919 | 50 | 77 | 0.58 | 27.85 |  |
| 156 | Profiles of Drug Substances, Excipients and Related Methodology | journal | 0.264 Q4 | 29 | 8 | 35 | 717 | 42 | 0 | 1.59 | 89.63 | |
| 155 | Molecular Therapy - Oncolytics | journal | 0.272 Q4 | 42 | 22 | 6 | 1480 | 4 | 5 | 0.67 | 67.27 | |
| 154 | Nucleosides, Nucleotides and Nucleic Acids | journal | 0.285 Q4 | 53 | 64 | 184 | 2161 | 203 | 184 | 1.06 | 33.77 | |
| 153 | Gene Therapy and Regulation | journal | 0.292 Q4 | 7 | 0 | 5 | 0 | 12 | 5 | 0.00 | 0.00 |  |
| 152 | EXCLI Journal | journal | 0.302 Q4 | 55 | 121 | 285 | 5643 | 378 | 245 | 1.48 | 46.64 | |
| 151 | Drug Discovery Today: Disease Models | journal | 0.310 Q4 | 33 | 22 | 93 | 1027 | 56 | 82 | 0.63 | 46.68 | |
| 150 | Open Medicinal Chemistry Journal | journal | 0.310 Q4 | 23 | 3 | 15 | 116 | 23 | 15 | 1.64 | 38.67 | |
| 149 | MCB Molecular and Cellular Biomechanics | journal | 0.312 Q4 | 31 | 17 | 43 | 578 | 56 | 43 | 1.26 | 34.00 | |
| 148 | Current Computer-Aided Drug Design | journal | 0.322 Q4 | 32 | 46 | 117 | 1537 | 157 | 106 | 1.32 | 33.41 | |
| 147 | Journal of Experimental Pharmacology | journal | 0.323 Q4 | 23 | 4 | 4 | 322 | 9 | 4 | 3.00 | 80.50 |  |
| 146 | Letters in Drug Design and Discovery | journal | 0.324 Q4 | 37 | 102 | 395 | 3479 | 397 | 391 | 1.06 | 34.11 | |
| 145 | Personalized Medicine | journal | 0.325 Q4 | 36 | 65 | 271 | 2851 | 256 | 229 | 0.95 | 43.86 | |
| 144 | Drug Discovery Today: Therapeutic Strategies | journal | 0.337 Q4 | 31 | 0 | 49 | 0 | 37 | 44 | 0.50 | 0.00 | |
| 143 | International Journal of Peptide Research and Therapeutics | journal | 0.340 Q4 | 45 | 52 | 147 | 1873 | 155 | 146 | 1.01 | 36.02 | |
| 142 | Analytical Cellular Pathology | journal | 0.354 Q4 | 35 | 42 | 66 | 2353 | 73 | 63 | 0.93 | 56.02 |  |
| 141 | Journal of Asian Natural Products Research | journal | 0.368 Q4 | 51 | 159 | 511 | 2864 | 628 | 511 | 1.18 | 18.01 | |
| 140 | Biotechnology and Applied Biochemistry | journal | 0.411 Q4 | 81 | 102 | 223 | 3446 | 309 | 220 | 1.43 | 33.78 | |
| 139 | Journal of Stem Cells | journal | 0.416 Q3 | 21 | 23 | 56 | 700 | 78 | 55 | 1.57 | 30.43 | |
| 138 | BMC Chemical Biology | journal | 0.423 Q3 | 21 | 0 | 5 | 0 | 14 | 5 | 0.00 | 0.00 | |
| 137 | Drug Discovery Today: Disease Mechanisms | journal | 0.433 Q3 | 28 | 0 | 27 | 0 | 29 | 24 | 1.44 | 0.00 | |
| 136 | Mini-Reviews in Medicinal Chemistry | journal | 0.437 | 107 | 118 | 399 | 9356 | 1258 | 384 | 3.12 | 79.29 | |
| 135 | SAR and QSAR in Environmental Research | journal | 0.469 Q3 | 54 | 55 | 152 | 2528 | 285 | 149 | 1.99 | 45.96 | |
| 134 | BBA Clinical | journal | 0.475 Q3 | 35 | 56 | 24 | 3144 | 33 | 22 | 1.38 | 56.14 | |
| 133 | Cellular Oncology | journal | 0.495 Q3 | 44 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
| 132 | Central Nervous System Agents in Medicinal Chemistry | journal | 0.506 Q3 | 39 | 25 | 69 | 964 | 124 | 61 | 1.66 | 38.56 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data